BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9510444)

  • 1. Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease.
    Koyanagi H; Nakamura Y; Yanagawa H
    Acta Paediatr; 1998 Jan; 87(1):32-6. PubMed ID: 9510444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-control study of giant coronary aneurysms due to Kawasaki disease.
    Nakamura Y; Yashiro M; Uehara R; Watanabe M; Tajimi M; Oki I; Ojima T; Yanagawa H
    Pediatr Int; 2003 Aug; 45(4):410-3. PubMed ID: 12911476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
    Sudo D; Monobe Y; Yashiro M; Sadakane A; Uehara R; Nakamura Y
    Pediatr Int; 2010 Oct; 52(5):790-4. PubMed ID: 20487371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease.
    Nakamura Y; Yashiro M; Uehara R; Watanabe M; Tajimi M; Oki I; Ojima T; Sonobe T; Yanagawa H
    Pediatr Int; 2004 Feb; 46(1):33-8. PubMed ID: 15043662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
    Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
    Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D; Yeo Y; Ha K; Jang G; Lee J; Lee K; Son C; Lee J
    Eur J Pediatr; 2009 Nov; 168(11):1315-21. PubMed ID: 19159953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant coronary aneurysms due to Kawasaki disease: a case-control study.
    Nakamura Y; Yashiro M; Oki I; Tanihara S; Ojima T; Yanagawa H
    Pediatr Int; 2002 Jun; 44(3):254-8. PubMed ID: 11982891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE; McCrindle BW; Laxer RM; Feldman BM; Schneider R; Silverman ED
    Pediatr Cardiol; 2003; 24(2):122-6. PubMed ID: 12457252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors related to cardiac sequelae of Kawasaki disease.
    Zhang T; Yanagawa H; Oki I; Nakamura Y; Yashiro M; Ojima T; Tanihara S
    Eur J Pediatr; 1999 Sep; 158(9):694-7. PubMed ID: 10485297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications.
    Sawaji Y; Haneda N; Yamaguchi S; Kajino Y; Kishida K; Seto S; Konishi N; Waki K; Baba K; Arisawa K; Kamiya T; Mori C
    Acta Paediatr Jpn; 1998 Jun; 40(3):218-25. PubMed ID: 9695293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.
    Kuwabara M; Yashiro M; Kotani K; Tsuboi S; Ae R; Nakamura Y; Yanagawa H; Kawasaki T
    J Epidemiol; 2015; 25(3):189-93. PubMed ID: 25716055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.
    Liu MY; Liu HM; Wu CH; Chang CH; Huang GJ; Chen CA; Chiu SN; Lu CW; Lin MT; Chang LY; Wang JK; Wu MH
    BMC Pediatr; 2017 Jun; 17(1):139. PubMed ID: 28587647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease.
    Tsuda E; Hamaoka K; Suzuki H; Sakazaki H; Murakami Y; Nakagawa M; Takasugi H; Yoshibayashi M
    Am Heart J; 2014 Feb; 167(2):249-58. PubMed ID: 24439987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
    Yamashita M; Ae R; Yashiro M; Aoyama Y; Sano T; Makino N; Nakamura Y
    Pediatr Cardiol; 2017 Feb; 38(2):375-380. PubMed ID: 27878631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alanine aminotransferase concentrations in patients with Kawasaki disease.
    Uehara R; Yashiro M; Hayasaka S; Oki I; Nakamura Y; Muta H; Ishii M; Matsuishi T; Sonobe T; Yanagawa H
    Pediatr Infect Dis J; 2003 Sep; 22(9):839-42. PubMed ID: 14515833
    [No Abstract]   [Full Text] [Related]  

  • 16. Giant coronary artery aneurysms complicating Kawasaki disease in Mexican children.
    Garrido-García LM; Morán-Villaseñor E; Yamazaki-Nakashimada MA; Cravioto P; Galván F
    Cardiol Young; 2018 Mar; 28(3):386-390. PubMed ID: 28847341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and psychosocial health in children who have had Kawasaki disease.
    Baker AL; Gauvreau K; Newburger JW; Sundel RP; Fulton DR; Jenkins KJ
    Pediatrics; 2003 Mar; 111(3):579-83. PubMed ID: 12612239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide survey of coronary aneurysms with diameter >6 mm in Kawasaki disease in Korea.
    Jang GY; Kang IS; Choi JY; Bae EJ; Kim YH; Kim SH; Ma JS
    Pediatr Int; 2015 Jun; 57(3):367-72. PubMed ID: 25406095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant coronary artery aneurysms in Kawasaki disease: the cost of a missed diagnosis.
    Marta L; Francisco A; Anjos R
    Cardiol Young; 2013 Aug; 23(4):608-9. PubMed ID: 23910022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six principal symptoms and coronary artery sequelae in Kawasaki disease.
    Nakamura Y; Yashiro M; Sadakane A; Aoyama Y; Oki I; Uehara R; Yanagawa H
    Pediatr Int; 2009 Oct; 51(5):705-8. PubMed ID: 19419505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.